Difference between revisions of "Example orders for Cetuximab (Erbitux) in colon cancer"
Jump to navigation
Jump to search
m (Text replacement - "{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center" | <span style="font-family:Arial; font-size:300%"> Just 8 days left to fill out a survey on how we can make HemOnc.org better and more useful.<br> '''Link:''' http://j.mp/2BlBaoQ </span> |}" to "{{:Editing test page 2}}") |
Warner-admin (talk | contribs) m (Text replacement - "{{:Editing test page 2}}<br>" to "") |
||
Line 1: | Line 1: | ||
− | + | '''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].''' | |
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. |
Revision as of 13:12, 1 February 2018
Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Cetuximab (Erbitux)
Original references may be found at Cetuximab (Erbitux)
Example regimen #1
For cycle 1:
- Cetuximab (Erbitux) 400 mg/m2 IV over 2 hours on day 1
- Use non-DEHP/paclitaxel tubing.
- Cetuximab (Erbitux) 250 mg/m2 IV over 60 minutes on days 8, 15, 22
- Use non-DEHP/paclitaxel tubing.
28-day cycle
Supportive medications
- Acetaminophen (Tylenol) 650 mg PO 30 minutes prior to cetuximab
- Diphenhydramine (Benadryl) 50 mg IV 30 minutes prior to cetuximab
Hydration:
- 500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS.
Monitoring:
- Hold if ANC <1000 or platelets <100 and notify physician.
For cycle 2 and later:
- Cetuximab (Erbitux) 250 mg/m2 IV over 60 minutes on days 1, 8, 15, 22
- Use non-DEHP/paclitaxel tubing.
28-day cycles
Supportive medications
- Acetaminophen (Tylenol) 650 mg PO 30 minutes prior to cetuximab
- Diphenhydramine (Benadryl) 50 mg IV 30 minutes prior to cetuximab
Hydration:
- 500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS.
Monitoring:
- Hold if ANC <1000 or platelets <100 and notify physician.
Comments:
- My institution uses 28-day cycles for Cetuximab (Erbitux) regimens.